Tumour Heterogeneity: The Key Advantages of Single-Cell Analysis
暂无分享,去创建一个
[1] Nithya Ramnath,et al. Optimizing the Detection of Circulating Markers to Aid in Early Lung Cancer Detection , 2016, Cancers.
[2] B. Nielsen,et al. Intratumoral Heterogeneity of MicroRNA Expression in Rectal Cancer , 2016, PloS one.
[3] Fiona Ginty,et al. Multiplexed immunofluorescence delineates proteomic cancer cell states associated with metabolism. , 2016, JCI insight.
[4] Mehmet Toner,et al. Clusters of circulating tumor cells traverse capillary-sized vessels , 2016, Proceedings of the National Academy of Sciences.
[5] F. Tang,et al. Single-cell sequencing in stem cell biology , 2016, Genome Biology.
[6] Jun S. Song,et al. Intratumoral Heterogeneity of the Epigenome. , 2016, Cancer cell.
[7] D. Heymann,et al. Circulating Tumor Cells: A Review of Non-EpCAM-Based Approaches for Cell Enrichment and Isolation. , 2016, Clinical chemistry.
[8] A. Vannucchi,et al. Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer , 2016, Oncotarget.
[9] W. Koh,et al. Single-cell genome sequencing: current state of the science , 2016, Nature Reviews Genetics.
[10] Florian Engert,et al. Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency , 2015, Nature Communications.
[11] Shuang Hou,et al. A comparison of isolated circulating tumor cells and tissue biopsies using whole-genome sequencing in prostate cancer , 2015, Oncotarget.
[12] D. Weitz,et al. Single-cell ChIP-seq reveals cell subpopulations defined by chromatin state , 2015, Nature Biotechnology.
[13] C. Swanton,et al. The National Lung Matrix Trial: translating the biology of stratification in advanced non-small-cell lung cancer , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.
[14] J. Luo,et al. Serial blood-based analysis of AR-V7 in men with advanced prostate cancer. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.
[15] Franziska Michor,et al. In situ single cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2+ breast cancer , 2015, Nature Genetics.
[16] Carlos Caldas,et al. Maintaining Tumor Heterogeneity in Patient-Derived Tumor Xenografts. , 2015, Cancer research.
[17] Ash A. Alizadeh,et al. Toward understanding and exploiting tumor heterogeneity , 2015, Nature Medicine.
[18] X. Zhuang,et al. Spatially resolved, highly multiplexed RNA profiling in single cells , 2015, Science.
[19] D. Planchard,et al. High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancer , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.
[20] Peng Qiu,et al. Single‐cell mass cytometry reveals intracellular survival/proliferative signaling in FLT3‐ITD‐mutated AML stem/progenitor cells , 2015, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[21] M. Pestrin,et al. Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients , 2015, Molecular oncology.
[22] Michael Kerger,et al. Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer , 2015, Nature Communications.
[23] B. Lim,et al. Non‐invasive sensitive detection of KRAS and BRAF mutation in circulating tumor cells of colorectal cancer patients , 2015, Molecular oncology.
[24] M. Nykter,et al. The Evolutionary History of Lethal Metastatic Prostate Cancer , 2015, Nature.
[25] Nathan C. Sheffield,et al. Single-Cell DNA Methylome Sequencing and Bioinformatic Inference of Epigenomic Cell-State Dynamics , 2015, Cell reports.
[26] Kun Zhang,et al. Fluorescent in situ sequencing (FISSEQ) of RNA for gene expression profiling in intact cells and tissues , 2015, Nature Protocols.
[27] Jin-Ling Tang,et al. Concordant analysis of KRAS, BRAF, PIK3CA mutations, and PTEN expression between primary colorectal cancer and matched metastases , 2015, Scientific Reports.
[28] S. Beck,et al. Analysis pipelines and packages for Infinium HumanMethylation450 BeadChip (450k) data , 2015, Methods.
[29] Siddharth S. Dey,et al. Integrated genome and transcriptome sequencing from the same cell , 2014, Nature Biotechnology.
[30] Christopher J. Sevinsky,et al. Emerging Understanding of Multiscale Tumor Heterogeneity , 2014, Front. Oncol..
[31] W. Koh,et al. Dissecting the clonal origins of childhood acute lymphoblastic leukemia by single-cell genomics , 2014, Proceedings of the National Academy of Sciences.
[32] Klaus Pantel,et al. Biology, detection, and clinical implications of circulating tumor cells , 2014, EMBO molecular medicine.
[33] V. Georgoulias,et al. PIK3CA Mutational Status in Circulating Tumor Cells Can Change During Disease Recurrence or Progression in Patients with Breast Cancer , 2014, Clinical Cancer Research.
[34] Nicolò Manaresi,et al. Molecular profiling of single circulating tumor cells with diagnostic intention , 2014, EMBO molecular medicine.
[35] Massimo Cristofanilli,et al. CTC enumeration and characterization: moving toward personalized medicine. , 2014, Annals of translational medicine.
[36] Laura Austin,et al. TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients , 2014, Breast Cancer Research.
[37] N. Navin. Cancer genomics: one cell at a time , 2014, Genome Biology.
[38] E. Rappaport,et al. Dielectrophoretic Capture and Genetic Analysis of Single Neuroblastoma Tumor Cells , 2014, Frontiers in Oncology.
[39] A. Saliba,et al. Single-cell RNA-seq: advances and future challenges , 2014, Nucleic acids research.
[40] Sridhar Ramaswamy,et al. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility , 2014, Science.
[41] Mark Cobbold,et al. Tracking Genomic Cancer Evolution for Precision Medicine: The Lung TRACERx Study , 2014, PLoS biology.
[42] J. Reis-Filho,et al. Breast cancer intra-tumor heterogeneity , 2014, Breast Cancer Research.
[43] C. Couldrey,et al. Exploring genome wide bisulfite sequencing for DNA methylation analysis in livestock: a technical assessment , 2014, Front. Genet..
[44] Eric Baudin,et al. Integrated genomic characterization of adrenocortical carcinoma , 2014, Nature Genetics.
[45] Timothy B Lannin,et al. Microfluidic immunocapture of circulating pancreatic cells using parallel EpCAM and MUC1 capture: characterization, optimization and downstream analysis. , 2014, Lab on a chip.
[46] Klaus Pantel,et al. [The circulating tumor cells: liquid biopsy of cancer]. , 2014, Klinicheskaia laboratornaia diagnostika.
[47] K. Pantel,et al. Technologies for detection of circulating tumor cells: facts and vision. , 2014, Lab on a chip.
[48] X. Xie,et al. Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients , 2013, Proceedings of the National Academy of Sciences.
[49] D. Hayes,et al. Circulating tumour cells: insights into tumour heterogeneity , 2013, Journal of internal medicine.
[50] Wainer Zoli,et al. Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs. , 2013, Cancer letters.
[51] S. Sleijfer,et al. KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue , 2013, International journal of cancer.
[52] M. Fang,et al. Genomic Profiling Defines Subtypes of Prostate Cancer with the Potential for Therapeutic Stratification , 2013, Clinical Cancer Research.
[53] Peter Ulz,et al. Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing. , 2013, Cancer research.
[54] Kornelia Polyak,et al. Cellular heterogeneity and molecular evolution in cancer. , 2013, Annual review of pathology.
[55] L. Pusztai,et al. Cancer heterogeneity: implications for targeted therapeutics , 2013, British Journal of Cancer.
[56] S. Kobayashi,et al. Compound EGFR Mutations and Response to EGFR Tyrosine Kinase Inhibitors , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[57] A. Viale,et al. Comparative genomic analysis of primary versus metastatic colorectal carcinomas. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[58] T. Mok,et al. EGFR mutation heterogeneity and the mixed response to EGFR tyrosine kinase inhibitors of lung adenocarcinomas. , 2012, The oncologist.
[59] G. Botti,et al. BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[60] Gyan Bhanot,et al. Single Cell Profiling of Circulating Tumor Cells: Transcriptional Heterogeneity and Diversity from Breast Cancer Cell Lines , 2012, PloS one.
[61] K. Polyak,et al. Intra-tumour heterogeneity: a looking glass for cancer? , 2012, Nature Reviews Cancer.
[62] Jorge S Reis-Filho,et al. Genetic heterogeneity and cancer drug resistance. , 2012, The Lancet. Oncology.
[63] Huanming Yang,et al. Single-Cell Exome Sequencing Reveals Single-Nucleotide Mutation Characteristics of a Kidney Tumor , 2012, Cell.
[64] J. Dannenberg,et al. Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance. , 2012, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[65] J. Feliu,et al. Analysis of the concordance in the EGFR pathway status between primary tumors and related metastases of colorectal cancer patients:implications for cancer therapy. , 2012, Current cancer drug targets.
[66] T. Saida,et al. Mutation analysis of BRAF and KIT in circulating melanoma cells at the single cell level , 2012, British Journal of Cancer.
[67] P. V. van Diest,et al. Primary Colorectal Cancers and Their Subsequent Hepatic Metastases Are Genetically Different: Implications for Selection of Patients for Targeted Treatment , 2011, Clinical Cancer Research.
[68] Stephanie Alexander,et al. Cancer Invasion and the Microenvironment: Plasticity and Reciprocity , 2011, Cell.
[69] K. Polyak,et al. The microenvironment in breast cancer progression: biology and implications for treatment , 2011, Breast Cancer Research.
[70] G. Nolan,et al. Association of Reactive Oxygen Species-Mediated Signal Transduction with In Vitro Apoptosis Sensitivity in Chronic Lymphocytic Leukemia B Cells , 2011, PloS one.
[71] Sean C. Bendall,et al. Extracting a Cellular Hierarchy from High-dimensional Cytometry Data with SPADE , 2011, Nature Biotechnology.
[72] Fabrice Merenda,et al. Microfluidic array cytometer based on refractive optical tweezers for parallel trapping, imaging and sorting of individual cells. , 2011, Lab on a chip.
[73] Nicholas Navin,et al. Future medical applications of single-cell sequencing in cancer , 2011, Genome Medicine.
[74] J. Troge,et al. Tumour evolution inferred by single-cell sequencing , 2011, Nature.
[75] A. Oudenaarden,et al. Validating transcripts with probes and imaging technology , 2011, Nature Methods.
[76] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[77] Jane E. Visvader,et al. Cells of origin in cancer , 2011, Nature.
[78] M. Esteller,et al. Aberrant epigenetic landscape in cancer: how cellular identity goes awry. , 2010, Developmental cell.
[79] Franziska Michor,et al. The Origins and Implications of Intratumor Heterogeneity , 2010, Cancer Prevention Research.
[80] M. Esteller,et al. Epigenetic modifications and human disease , 2010, Nature Biotechnology.
[81] T. Graeber,et al. Integrated Systems and Technologies Cancer Research A Microfluidic Platform for Systems Pathology : Multiparameter Single-Cell Signaling Measurements of Clinical Brain Tumor Specimens , 2010 .
[82] J. Nevins,et al. Mouse models of cancers: opportunities to address heterogeneity of human cancer and evaluate therapeutic strategies , 2010, Journal of Molecular Medicine.
[83] Ash A. Alizadeh,et al. B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression , 2010, Proceedings of the National Academy of Sciences.
[84] A. Nassar,et al. Intratumoral Heterogeneity of Immunohistochemical Marker Expression in Breast Carcinoma: A Tissue Microarray-based Study , 2010, Applied immunohistochemistry & molecular morphology : AIMM.
[85] Y. Kimura,et al. Developments and applications of mass microscopy , 2010, Medical Molecular Morphology.
[86] T. Halazonetis,et al. Genomic instability — an evolving hallmark of cancer , 2010, Nature Reviews Molecular Cell Biology.
[87] M. Gönen,et al. Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype. , 2010, The Journal of clinical investigation.
[88] Ryan D. Morin,et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution , 2009, Nature.
[89] O. Ornatsky,et al. Mass cytometry: technique for real time single cell multitarget immunoassay based on inductively coupled plasma time-of-flight mass spectrometry. , 2009, Analytical chemistry.
[90] Jonathan M Irish,et al. Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates. , 2008, Cancer cell.
[91] J. Visvader,et al. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions , 2008, Nature Reviews Cancer.
[92] M. Wicha. Cancer stem cell heterogeneity in hereditary breast cancer , 2008, Breast Cancer Research.
[93] Marc Ladanyi,et al. Heterogeneity of Breast Cancer Metastases: Comparison of Therapeutic Target Expression and Promoter Methylation Between Primary Tumors and Their Multifocal Metastases , 2008, Clinical Cancer Research.
[94] R. Place,et al. MicroRNA-373 induces expression of genes with complementary promoter sequences , 2008, Proceedings of the National Academy of Sciences.
[95] Michael R. Speicher,et al. High resolution array-CGH analysis of single cells , 2006, Nucleic acids research.
[96] A. Lichtenstein. Clonal heterogeneity of tumor may be due to continuous influx of newly transformed cells , 2006, Cancer biology & therapy.
[97] P. Steeg. Tumor metastasis: mechanistic insights and clinical challenges , 2006, Nature Medicine.
[98] L. Coussens,et al. Tumor stroma and regulation of cancer development. , 2006, Annual review of pathology.
[99] B. Ylstra,et al. Microarray‐based comparative genomic hybridization and its applications in human genetics , 2004, Clinical genetics.
[100] D. Pinkel,et al. High‐resolution genomic profiling of occult micrometastatic tumor cells , 2003, Genes, chromosomes & cancer.
[101] J. Köllermann,et al. Heterogeneous proliferative potential of occult metastatic cells in bone marrow of patients with solid epithelial tumors , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[102] Adrian E. Raftery,et al. Model-based clustering and data transformations for gene expression data , 2001, Bioinform..
[103] Anthony J. Guidi,et al. Association of angiogenesis in lymph node metastases with outcome of breast cancer. , 2000, Journal of the National Cancer Institute.
[104] E. Petricoin,et al. Laser Capture Microdissection , 1996, Science.
[105] I. Fidler,et al. Biological diversity in metastatic neoplasms: origins and implications. , 1982, Science.
[106] P. Nowell. The clonal evolution of tumor cell populations. , 1976, Science.
[107] U. Demirci,et al. KRAS discordance between primary and metastatic tumor in patients with metastatic colorectal carcinoma. , 2015, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.
[108] K. Pantel,et al. Whole Genome Amplification in Genomic Analysis of Single Circulating Tumor Cells. , 2015, Methods in molecular biology.
[109] L. Esserman,et al. Expression profiling of circulating tumor cells in metastatic breast cancer , 2014, Breast Cancer Research and Treatment.
[110] J. Izbicki,et al. Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/PIK3CA in circulating tumor cells of patients with colorectal cancer. , 2013, Clinical chemistry.
[111] J. Flanagan,et al. RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. , 2012, The Journal of molecular diagnostics : JMD.
[112] V. Chekhun,et al. [Evaluation of biological effects and possible mechanisms of action of static magnetic field]. , 2012, Fiziolohichnyi zhurnal.
[113] M. Herlyn,et al. Intratumoral heterogeneity as a therapy resistance mechanism: role of melanoma subpopulations. , 2012, Advances in pharmacology.
[114] Chekhun Vf,et al. Evaluation of biological effects and possible mechanisms of action of static magnetic field , 2012 .
[115] Donald Wlodkowic,et al. Rise of the micromachines: microfluidics and the future of cytometry. , 2011, Methods in cell biology.
[116] J. Salk. Clonal evolution in cancer , 2010 .
[117] J. Shipley,et al. Fluorescence and chromogenic in situ hybridization to detect genetic aberrations in formalin-fixed paraffin embedded material, including tissue microarrays , 2008, Nature Protocols.
[118] G. Dakubo,et al. Clinical implications and utility of field cancerization , 2007, Cancer Cell International.